login

Lithium as an immunologic adjuvant

Medical HypothesesPublished 1 January 1980
Louis Shenkman, William Borkowsky, Baron Shopsin
Citations40
SJR quartileQ3
SJR score0.39
SNIP0.33

TL;DR

Lithium, an adenylate cyclase inhibitor, stimulates a variety of in vitro indices of immune function, including proliferation of lymphocytes in response to mitogens, rosette formation by T-cells and phagocytosis by macrophages.

Abstract

Lithium, an adenylate cyclase inhibitor, stimulates a variety of in vitro indices of immune function, including proliferation of lymphocytes in response to mitogens, rosette formation by T-cells and phagocytosis by macrophages. Lithium enhances these immunologic responses at concentrations comparable to those achieved in patients receiving lithium for treatment of manic-depressive disorders. Lithium may prove to have important therapeutic applications as an immune adjuvant, particularly in immune deficiency states associated with excessive C-AMP production.

Keywords

Immunology and MicrobiologyMedicine